iTeos Therapeutics, Inc. (ITOS) has 81 open-market insider trades by 27 insiders since 2020. The most active filer is Michel Detheux, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Aaron I. Davis | — | — | 5 | $70.7M | 2024-05-10 |
| MVA Investors, LLC | Dir10% Owner | — | 1 | $65.1M | 2022-01-04 |
| EcoR1 Capital, LLC | 10% Owner | — | 1 | $51.0M | 2025-05-15 |
| Boxer Capital, LLC via Aaron I. Davis | 10% Owner | — | 1 | $40.6M | 2022-03-17 |
| Ansbert Gadicke | 10% Owner | — | 5 | $28.4M | 2022-01-05 |
| Rajeev M. Shah | 10% Owner | — | 1 | $27.1M | 2020-07-28 |
| MPM BioVentures 2018 GP LLC | — | — | 5 | $25.2M | 2025-05-13 |
| Oncology Impact Fund (Cayman) Management L.P. | 10% Owner | — | 7 | $18.3M | 2021-12-07 |
| MPM BioImpact LLC | — | — | 1 | $16.6M | 2025-05-13 |
| Luke Evnin | 10% Owner | — | 5 | $9.5M | 2021-12-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michel Detheux | CEO | Sell | $1.9M | 2025-06-09 |
| David Hallal | Director | Sell | $2.3M | 2025-06-04 |
| Michel Detheux | CEO | Sell | $2.9M | 2025-06-04 |
| EcoR1 Capital, LLC | 10% Owner | Buy | $51.0M | 2025-05-14 |
| MPM BioImpact LLC | — | Sell | $16.6M | 2025-05-13 |
| MPM BioVentures 2018 GP LLC | — | Sell | $10.2M | 2025-05-13 |
Companies that share insiders with ITOS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| MPM Bioventures 2018 (b), L.P. | — | Sell | $5.1M | 2025-05-13 |
| Matthew Gall | CFO | Buy | $39K | 2024-11-19 |
| Matthew Gall | CFO | Buy | $42K | 2023-10-12 |
| Aaron I. Davis | — | Sell | $11.4M | 2023-08-23 |
| David Hallal | Director | Sell | $1.2M | 2022-06-08 |
| Aaron I. Davis | Director | Sell | $20.2M | 2022-05-09 |
| Aaron I. Davis | Director | Sell | $10.2M | 2022-04-28 |
| Michel Detheux | CEO | Sell | $732K | 2022-04-18 |
| Michel Detheux | CEO | Sell | $1.2M | 2022-03-22 |